{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T20:17:23Z","timestamp":1761164243910,"version":"build-2065373602"},"reference-count":56,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Liver Disease"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.cld.2022.01.010","type":"journal-article","created":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T07:28:16Z","timestamp":1648798096000},"page":"255-268","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Peritransplant Renal Dysfunction in Liver Transplant Candidates"],"prefix":"10.1016","volume":"26","author":[{"given":"Rajiv","family":"Heda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander J.","family":"Kovalic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjaya K.","family":"Satapathy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"13","key":"10.1016\/j.cld.2022.01.010_bib1","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1056\/NEJMra0809139","article-title":"Renal failure in cirrhosis","volume":"361","author":"Gin\u00e8s","year":"2009","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.cld.2022.01.010_bib2","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.jhep.2011.10.016","article-title":"Renal failure and cirrhosis: a systematic review of mortality and prognosis","volume":"56","author":"Fede","year":"2012","journal-title":"J\u00a0Hepatol"},{"issue":"12","key":"10.1016\/j.cld.2022.01.010_bib3","doi-asserted-by":"crossref","first-page":"e13428","DOI":"10.1111\/ctr.13428","article-title":"Pre-liver transplant renal dysfunction and association with post-transplant end-stage renal disease: a single-center examination of updated UNOS recommendations","volume":"32","author":"Chauhan","year":"2018","journal-title":"Clin Transplant"},{"issue":"10","key":"10.1016\/j.cld.2022.01.010_bib4","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1056\/NEJMoa021744","article-title":"Chronic renal failure after transplantation of a nonrenal organ","volume":"349","author":"Ojo","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cld.2022.01.010_bib5","doi-asserted-by":"crossref","first-page":"751","DOI":"10.12659\/AOT.911030","article-title":"Association between renal dysfunction and major adverse cardiac events after liver transplantation: evidence from an international randomized trial of everolimus-based immunosuppression","volume":"23","author":"Saliba","year":"2018","journal-title":"Ann Transplant"},{"issue":"10","key":"10.1016\/j.cld.2022.01.010_bib6","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1097\/01.tp.0000261630.63550.41","article-title":"Sirolimus conversion in liver transplant recipients with renal dysfunction: a prospective, randomized, single-center trial","volume":"83","author":"Shenoy","year":"2007","journal-title":"Transplantation"},{"issue":"7","key":"10.1016\/j.cld.2022.01.010_bib7","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1053\/jlts.2003.50113","article-title":"Independent risk factors and natural history of renal dysfunction in liver transplant recipients","volume":"9","author":"Pawarode","year":"2003","journal-title":"Liver Transpl"},{"issue":"6","key":"10.1016\/j.cld.2022.01.010_bib8","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/sj.ki.5000216","article-title":"Risk factors of acute renal failure after liver transplantation","volume":"69","author":"Cabezuelo","year":"2006","journal-title":"Kidney Int"},{"issue":"5","key":"10.1016\/j.cld.2022.01.010_bib9","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1136\/gut.2010.236133","article-title":"Working party proposal for a revised classification system of renal dysfunction in patients with cirrhosis","volume":"60","author":"Wong","year":"2011","journal-title":"Gut"},{"issue":"Suppl 4","key":"10.1016\/j.cld.2022.01.010_bib10","article-title":"Renal dysfunction in liver transplant candidates: evaluation, classification and management in contemporary practice","author":"Gleisner","year":"2012","journal-title":"J\u00a0Nephrol Ther"},{"issue":"7","key":"10.1016\/j.cld.2022.01.010_bib11","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1111\/j.1572-0241.2001.03958.x","article-title":"Risk factors for the development of renal dysfunction in hospitalized patients with cirrhosis","volume":"96","author":"Hampel","year":"2001","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"10.1016\/j.cld.2022.01.010_bib12","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1053\/j.gastro.2010.07.043","article-title":"Prognostic importance of the cause of renal failure in patients with cirrhosis","volume":"140","author":"Mart\u00edn-Llah\u00ed","year":"2011","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.cld.2022.01.010_bib13","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1053\/jhep.2003.50315","article-title":"The management of ascites in cirrhosis: report on the consensus conference of the International Ascites Club","volume":"38","author":"Moore","year":"2003","journal-title":"Hepatol"},{"issue":"2","key":"10.1016\/j.cld.2022.01.010_bib14","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/hep.1840200215","article-title":"Renal duplex Doppler ultrasonography: a noninvasive predictor of kidney dysfunction and hepatorenal failure in liver disease","volume":"20","author":"Platt","year":"1994","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.cld.2022.01.010_bib15","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.jhep.2004.05.009","article-title":"Effect of intravenous albumin on systemic and hepatic hemodynamics and vasoactive neurohormonal systems in patients with cirrhosis and spontaneous bacterial peritonitis","volume":"41","author":"Fern\u00e1ndez","year":"2004","journal-title":"J\u00a0Hepatol"},{"issue":"998","key":"10.1016\/j.cld.2022.01.010_bib16","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1136\/gut.2006.107789","article-title":"Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis","volume":"84","author":"Salerno","year":"2008","journal-title":"Postgrad Med J"},{"issue":"9","key":"10.1016\/j.cld.2022.01.010_bib17","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1056\/NEJMoa2008290","article-title":"Terlipressin plus albumin for the treatment of type 1 hepatorenal syndrome","volume":"384","author":"Wong","year":"2021","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1016\/j.cld.2022.01.010_bib18","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1097\/MCG.0b013e318188947c","article-title":"Combination treatment with octreotide, midodrine, and albumin improves survival in patients with type 1 and type 2 hepatorenal syndrome","volume":"43","author":"Skagen","year":"2009","journal-title":"J\u00a0Clin Gastroenterol"},{"issue":"17","key":"10.1016\/j.cld.2022.01.010_bib19","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.3748\/wjg.v27.i17.1864","article-title":"Non-alcoholic fatty liver and chronic kidney disease: retrospect, introspect, and prospect","volume":"27","author":"Heda","year":"2021","journal-title":"World J Gastroenterol"},{"issue":"3","key":"10.1016\/j.cld.2022.01.010_bib20","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1148\/radiology.183.3.1584937","article-title":"Renal dysfunction in hepatic disease: early identification with renal duplex Doppler US in patients who undergo liver transplantation","volume":"183","author":"Platt","year":"1992","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.cld.2022.01.010_bib21","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1136\/gut.50.1.106","article-title":"Evaluation of serum cystatin C concentration as a marker of renal function in patients with cirrhosis of the liver","volume":"50","author":"Gerbes","year":"2002","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.cld.2022.01.010_bib22","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1002\/hep.26556","article-title":"Performance of chronic kidney disease epidemiology collaboration creatinine-cystatin C equation for estimating kidney function in cirrhosis","volume":"59","author":"Mindikoglu","year":"2014","journal-title":"Hepatol"},{"issue":"3","key":"10.1016\/j.cld.2022.01.010_bib23","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.cld.2014.05.003","article-title":"Renal dysfunction in end-stage liver disease and post-liver transplant","volume":"18","author":"Sampaio","year":"2014","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.cld.2022.01.010_bib24","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1002\/lt.26216","article-title":"Estimating glomerular filtration rate in cirrhosis using creatinine-based and cystatin C-based equations: systematic review and meta-analysis","volume":"27","author":"Singapura","year":"2021","journal-title":"Liver Transpl"},{"issue":"2","key":"10.1016\/j.cld.2022.01.010_bib25","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jhep.2012.03.015","article-title":"Urinary neutrophil gelatinase-associated lipocalin as biomarker in the differential diagnosis of impairment of kidney function in cirrhosis","volume":"57","author":"Fagundes","year":"2012","journal-title":"J\u00a0Hepatol"},{"issue":"9","key":"10.1016\/j.cld.2022.01.010_bib26","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1007\/s10620-012-2180-x","article-title":"Urinary neutrophil gelatinase-associated lipocalin predicts mortality and identifies acute kidney injury in cirrhosis","volume":"57","author":"Verna","year":"2012","journal-title":"Dig Dis Sci"},{"issue":"2","key":"10.1016\/j.cld.2022.01.010_bib27","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/hep.26980","article-title":"Kidney biomarkers and differential diagnosis of patients with cirrhosis and acute kidney injury","volume":"60","author":"Belcher","year":"2014","journal-title":"Hepatol Aug"},{"issue":"6","key":"10.1016\/j.cld.2022.01.010_bib28","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1097\/MEG.0000000000001347","article-title":"Clinical utility of urinary neutrophil gelatinase-associated lipocalin and serum cystatin C in a cohort of liver cirrhosis patients with renal dysfunction: a challenge in the diagnosis of hepatorenal syndrome","volume":"31","author":"Gomaa","year":"2019","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.cld.2022.01.010_bib29","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/tri.13388","article-title":"Simultaneous liver kidney transplantation","volume":"32","author":"Singal","year":"2019","journal-title":"Transplant Int"},{"issue":"3","key":"10.1016\/j.cld.2022.01.010_bib30","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1097\/TP.0000000000000945","article-title":"Nonalcoholic steatohepatitis is the most rapidly growing indication for simultaneous liver kidney transplantation in the United States","volume":"100","author":"Singal","year":"2016","journal-title":"Transplant"},{"issue":"3","key":"10.1016\/j.cld.2022.01.010_bib31","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/lt.25367","article-title":"Association of pretransplant renal function with liver graft and patient survival after liver transplantation in patients with nonalcoholic steatohepatitis","volume":"25","author":"Molnar","year":"2019","journal-title":"Liver Transplant"},{"issue":"2","key":"10.1016\/j.cld.2022.01.010_bib32","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/tri.13352","article-title":"Obesity does not significantly impact outcomes following simultaneous liver kidney transplantation: review of the UNOS database - a retrospective study","volume":"32","author":"Yu","year":"2019","journal-title":"Transplant Int"},{"issue":"7","key":"10.1016\/j.cld.2022.01.010_bib33","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1002\/lt.23867","article-title":"Intraoperative hemodialysis during liver transplantation: a decade of experience","volume":"20","author":"Nadim","year":"2014","journal-title":"Liver Transplant"},{"issue":"5","key":"10.1016\/j.cld.2022.01.010_bib34","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/j.surg.2016.10.027","article-title":"Outcome analysis of continuous intraoperative renal replacement therapy in the highest acuity liver transplant recipients: a single-center experience","volume":"161","author":"Zimmerman","year":"2017","journal-title":"Surgery"},{"issue":"6","key":"10.1016\/j.cld.2022.01.010_bib35","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/j.transproceed.2017.03.094","article-title":"Benefits of intraoperative continuous renal replacement therapy during liver transplantation in patients with renal dysfunction","volume":"49","author":"Baek","year":"2017","journal-title":"Transplant Proc"},{"issue":"5","key":"10.1016\/j.cld.2022.01.010_bib36","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1016\/S0041-1345(03)00598-0","article-title":"Does the standard vs piggyback surgical technique affect the development of early acute renal failure after orthotopic liver transplantation?","volume":"35","author":"Cabezuelo","year":"2003","journal-title":"Transplant Proc"},{"issue":"5","key":"10.1016\/j.cld.2022.01.010_bib37","doi-asserted-by":"crossref","first-page":"e348","DOI":"10.1097\/TXD.0000000000000776","article-title":"Liver transplantation without venovenous bypass: does surgical approach matter?","volume":"4","author":"Barbas","year":"2018","journal-title":"Transplant Direct"},{"issue":"5","key":"10.1016\/j.cld.2022.01.010_bib38","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1213\/ANE.0000000000002311","article-title":"Venovenous bypass is associated with a lower incidence of acute kidney injury after liver transplantation in patients with compromised pretransplant renal function","volume":"125","author":"Sun","year":"2017","journal-title":"Anesth Analg"},{"issue":"10","key":"10.1016\/j.cld.2022.01.010_bib39","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1053\/jlts.2002.35668","article-title":"Chronic renal dysfunction late after liver transplantation","volume":"8","author":"Cohen","year":"2002","journal-title":"Liver Transpl"},{"issue":"1","key":"10.1016\/j.cld.2022.01.010_bib40","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/00007890-199807150-00010","article-title":"Chronic renal failure following liver transplantation: a retrospective analysis","volume":"66","author":"Fisher","year":"1998","journal-title":"Transplantation"},{"issue":"12","key":"10.1016\/j.cld.2022.01.010_bib41","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1097\/00007890-200112270-00012","article-title":"End-stage renal disease (ESRD) after orthotopic liver transplantation (OLTX) using calcineurin-based immunotherapy: risk of development and treatment","volume":"72","author":"Gonwa","year":"2001","journal-title":"Transplantation"},{"issue":"Suppl 6","key":"10.1016\/j.cld.2022.01.010_bib42","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1034\/j.1399-0012.2001.00013.x","article-title":"End-stage renal disease in liver transplants","volume":"15","author":"Lynn","year":"2001","journal-title":"Clin Transplant"},{"issue":"2","key":"10.1016\/j.cld.2022.01.010_bib43","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1053\/jlts.2002.31516","article-title":"Pathophysiology of renal disease associated with liver disorders: implications for liver transplantation. Part I","volume":"8","author":"Davis","year":"2002","journal-title":"Liver Transplant"},{"issue":"12 Suppl","key":"10.1016\/j.cld.2022.01.010_bib44","first-page":"Ss5","article-title":"Mechanisms of nephrotoxicity","volume":"69","author":"Campistol","year":"2000","journal-title":"Transplantation"},{"issue":"6","key":"10.1016\/j.cld.2022.01.010_bib45","doi-asserted-by":"crossref","first-page":"471","DOI":"10.2165\/00002018-199921060-00004","article-title":"Immunosuppressant-induced nephropathy: pathophysiology, incidence and management","volume":"21","author":"Olyaei","year":"1999","journal-title":"Drug Saf"},{"issue":"2","key":"10.1016\/j.cld.2022.01.010_bib46","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/ki.1994.44","article-title":"Loss of glomerular function and tubulointerstitial fibrosis: cause or effect?","volume":"45","author":"Ong","year":"1994","journal-title":"Kidney Int"},{"issue":"2","key":"10.1016\/j.cld.2022.01.010_bib47","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.12872","article-title":"Everolimus with early withdrawal or reduced-dose calcineurin inhibitors improves renal function in liver transplant recipients: a systematic review and meta-analysis","volume":"31","author":"Lin","year":"2017","journal-title":"Clin Transplant"},{"issue":"12","key":"10.1016\/j.cld.2022.01.010_bib48","doi-asserted-by":"crossref","first-page":"e13415","DOI":"10.1111\/ctr.13415","article-title":"Delayed calcineurin inhibitor introduction and renal outcomes in liver transplant recipients receiving basiliximab induction","volume":"32","author":"Lange","year":"2018","journal-title":"Clin Transplant"},{"issue":"5","key":"10.1016\/j.cld.2022.01.010_bib49","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/j.transproceed.2021.04.001","article-title":"Basiliximab with delayed tacrolimus improves short-term renal outcomes post-liver transplantation-a real-world experience","volume":"53","author":"Boyd","year":"2021","journal-title":"Transplant Proc"},{"issue":"1","key":"10.1016\/j.cld.2022.01.010_bib50","first-page":"Cd013203","article-title":"Induction immunosuppression in adults undergoing liver transplantation: a network meta-analysis","volume":"1","author":"Best","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"issue":"8","key":"10.1016\/j.cld.2022.01.010_bib51","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1002\/lt.20145","article-title":"Use of fenoldopam to control renal dysfunction early after liver transplantation","volume":"10","author":"Biancofiore","year":"2004","journal-title":"Liver Transplant"},{"key":"10.1016\/j.cld.2022.01.010_bib52","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1186\/s13054-015-1166-4","article-title":"Fenoldopam to prevent acute kidney injury after major surgery-a systematic review and meta-analysis","volume":"19","author":"Gillies","year":"2015","journal-title":"Crit Care"},{"issue":"6","key":"10.1016\/j.cld.2022.01.010_bib53","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1213\/01.ANE.0000136420.01393.81","article-title":"Fenoldopam mesylate and renal function in patients undergoing liver transplantation: a randomized, controlled pilot trial","volume":"99","author":"Rocca","year":"2004","journal-title":"Anesth Analg"},{"issue":"6","key":"10.1016\/j.cld.2022.01.010_bib54","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1097\/01.CCM.0000128560.57111.CD","article-title":"Recombinant human atrial natriuretic peptide in ischemic acute renal failure: a randomized placebo-controlled trial","volume":"32","author":"Sw\u00e4rd","year":"2004","journal-title":"Crit Care Med"},{"issue":"3","key":"10.1016\/j.cld.2022.01.010_bib55","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1053\/j.ajkd.2007.11.019","article-title":"Serum cystatin C in the United States: the third national health and nutrition examination survey (NHANES III)","volume":"51","author":"K\u00f6ttgen","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.cld.2022.01.010_bib57","doi-asserted-by":"crossref","unstructured":"Dopazo, C., Charco, R., Caralt, M., Pando, E., L\u00e1zaro, J. L., G\u00f3mez-Gavara, C., Castells, L., & Bilbao, I. (2018). Low Total Dose of Anti-Human T-Lymphocyte Globulin (ATG) Guarantees a Good Glomerular Filtration Rate after Liver Transplant in Recipients with Pretransplant Renal Dysfunction. Can J Gastroenterol Hepatol 2018.","DOI":"10.1155\/2018\/1672621"}],"container-title":["Clinics in Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326122000101?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326122000101?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T17:59:18Z","timestamp":1761069558000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1089326122000101"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":56,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S1089326122000101"],"URL":"https:\/\/doi.org\/10.1016\/j.cld.2022.01.010","relation":{},"ISSN":["1089-3261"],"issn-type":[{"type":"print","value":"1089-3261"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Peritransplant Renal Dysfunction in Liver Transplant Candidates","name":"articletitle","label":"Article Title"},{"value":"Clinics in Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cld.2022.01.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}